Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops
Clinical trial NCT04782271 · COMPLETED
Trial details
- NCT number
- NCT04782271
- Sponsor
- Sylentis, S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2021-12-21
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.